Skip to content

Dr Jannick Achtergaele

Active
Private limited companyfounded 2025active for 1 yearBrugstraat 3, 2820 Bonheiden, BelgiumKBO/BCE: BE 1028.709.051
Summary

Dr Jannick Achtergaele has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,494 and a net result of €2,160. Its solvency ranks better than 38% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 06-10-2025 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.379.276.772 2820 Bonheiden, since 06-10-2025
Financial year end
31 December
Peppol
Reachable since 04-03-2026

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€3,945
Turnover
≈ €25,000
estimated
Profit
€2,160
Equity
€3,494
Total assets
€7,141
Score breakdownraises riskFounded in 2025lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.96, cash €2,508Figures for financial year 2025 (filed on 30-06-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 74
equity 48.9% of total assets
Liquidity 68
short-term debt 51.1% · cash 35.1%
Profitability 100
return on assets 30.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 39% of them on solvency, 48% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.96, cash €2,508
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-06-2026)
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
31 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 92% of companies in human healthsector median €124,659 · 20,702 companies €3,494 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: ACHTERGAELE Jannick (director) · Permanent representative: ACHTERGAELE Jannick
All 2 events

Comparable companies

These companies have the same main activity as Dr Jannick Achtergaele: general medical practice (NACE 86210). They are comparable in size and age: total assets between €6,240 and €11,300, founded in 2025.

CompanyTotal assetsGross margin
Dr Jannick Achtergaele Bonheiden€7,141€3,945
Dr. Hadewich Vanneste Gent€7,271€4,271
AD And Partner Liège€9,362€4,258
Dr. Lisanne Merckx Leuven€11,313€3,726
A&B Medical Clinic Sint-Pieters-Woluwe€6,245€2,744
Dotoro Antwerpen€8,726€2,484
Dr. Khaila van Straaten Mechelen€8,608€2,368
Full comparison

Key facts about Dr Jannick Achtergaele

What is the company number of Dr Jannick Achtergaele?
The company number of Dr Jannick Achtergaele is 1028.709.051. The VAT number is the same number with BE in front: BE 1028.709.051.
Where is Dr Jannick Achtergaele based?
The registered office is at Brugstraat 3, 2820 Bonheiden.Company details
What does Dr Jannick Achtergaele do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr Jannick Achtergaele?
The legal form of Dr Jannick Achtergaele is Private limited company (BV).
When was Dr Jannick Achtergaele founded?
Dr Jannick Achtergaele was founded on 06-10-2025.
Is Dr Jannick Achtergaele still active?
Yes, Dr Jannick Achtergaele is an active enterprise in the KBO register.
What is the turnover of Dr Jannick Achtergaele?
The turnover in financial year 2025 is ≈ €25,000. This figure is estimated from the gross margin of €3,945 and 48 comparable companies (NACE 86). It probably lies between €17,000 and €41,000. It is a rough estimate.Financials
Is Dr Jannick Achtergaele profitable?
In financial year 2025, Dr Jannick Achtergaele made a profit of €2,160.
Where can I find the annual accounts of Dr Jannick Achtergaele?
Dr Jannick Achtergaele filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.